Depletion of Tregs or inhibition of the SOX2 pathway restores T cell infiltration and markedly suppresses tumor growth, suggesting that targeting the SOX2 pathway may synergistically enhance the therapeutic efficacy of ICIs (110). The gene discussed is SOX2; the disease is neoplasm.